Is a gene-centric human proteome project the best way for proteomics to serve biology?
Identifieur interne : 002383 ( PascalFrancis/Corpus ); précédent : 002382; suivant : 002384Is a gene-centric human proteome project the best way for proteomics to serve biology?
Auteurs : Thierry Rabilloud ; Denis Hochstrasser ; Richard J. SimpsonSource :
- Proteomics : (Weinheim. Print) [ 1615-9853 ] ; 2010.
Descripteurs français
English descriptors
Abstract
With the recent developments in proteomic technologies, a complete human proteome project (HPP) appears feasible for the first time. However, there is still debate as to how it should be designed and what it should encompass. In "proteomics speak", the debate revolves around the central question as to whether a gene-centric or a protein-centric proteomics approach is the most appropriate way forward. In this paper, we try to shed light on what these definitions mean, how large-scale proteomics such as a HPP can insert into the larger omics chorus, and what we can reasonably expect from a HPP in the way it has been proposed so far.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 10-0431596 INIST |
---|---|
ET : | Is a gene-centric human proteome project the best way for proteomics to serve biology? |
AU : | RABILLOUD (Thierry); HOCHSTRASSER (Denis); SIMPSON (Richard J.) |
AF : | Biochemistry and Biophysics of Integrated Systems, UMR CNRS-CEA-UJF 5092, CEA Grenoble, iRTSV/BSBBSI/Grenoble/France (1 aut.); Department of Genetic and Laboratory Medicine, Laboratory Medicine Division, Geneva University, Geneva University Hospital and Swiss Centre of Applied Human Toxicology/Geneva/Suisse (2 aut.); Ludwig Institute for Cancer Research Inc, Royal Melbourne Hospital/Parkville/Australie (3 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Proteomics : (Weinheim. Print); ISSN 1615-9853; Allemagne; Da. 2010; Vol. 10; No. 17; Pp. 3067-3072; Bibl. 50 ref. |
LA : | Anglais |
EA : | With the recent developments in proteomic technologies, a complete human proteome project (HPP) appears feasible for the first time. However, there is still debate as to how it should be designed and what it should encompass. In "proteomics speak", the debate revolves around the central question as to whether a gene-centric or a protein-centric proteomics approach is the most appropriate way forward. In this paper, we try to shed light on what these definitions mean, how large-scale proteomics such as a HPP can insert into the larger omics chorus, and what we can reasonably expect from a HPP in the way it has been proposed so far. |
CC : | 002A02D10 |
FD : | Homme; Gène; Protéome; Protéomique; Anticorps; Protéine |
ED : | Human; Gene; Proteome; Proteomics; Antibody; Protein |
SD : | Hombre; Gen; Proteoma; Proteómica; Anticuerpo; Proteína |
LO : | INIST-27206.354000194246300010 |
ID : | 10-0431596 |
Links to Exploration step
Pascal:10-0431596Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Is a gene-centric human proteome project the best way for proteomics to serve biology?</title>
<author><name sortKey="Rabilloud, Thierry" sort="Rabilloud, Thierry" uniqKey="Rabilloud T" first="Thierry" last="Rabilloud">Thierry Rabilloud</name>
<affiliation><inist:fA14 i1="01"><s1>Biochemistry and Biophysics of Integrated Systems, UMR CNRS-CEA-UJF 5092, CEA Grenoble, iRTSV/BSBBSI</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hochstrasser, Denis" sort="Hochstrasser, Denis" uniqKey="Hochstrasser D" first="Denis" last="Hochstrasser">Denis Hochstrasser</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Genetic and Laboratory Medicine, Laboratory Medicine Division, Geneva University, Geneva University Hospital and Swiss Centre of Applied Human Toxicology</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Simpson, Richard J" sort="Simpson, Richard J" uniqKey="Simpson R" first="Richard J." last="Simpson">Richard J. Simpson</name>
<affiliation><inist:fA14 i1="03"><s1>Ludwig Institute for Cancer Research Inc, Royal Melbourne Hospital</s1>
<s2>Parkville</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0431596</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0431596 INIST</idno>
<idno type="RBID">Pascal:10-0431596</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002383</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Is a gene-centric human proteome project the best way for proteomics to serve biology?</title>
<author><name sortKey="Rabilloud, Thierry" sort="Rabilloud, Thierry" uniqKey="Rabilloud T" first="Thierry" last="Rabilloud">Thierry Rabilloud</name>
<affiliation><inist:fA14 i1="01"><s1>Biochemistry and Biophysics of Integrated Systems, UMR CNRS-CEA-UJF 5092, CEA Grenoble, iRTSV/BSBBSI</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hochstrasser, Denis" sort="Hochstrasser, Denis" uniqKey="Hochstrasser D" first="Denis" last="Hochstrasser">Denis Hochstrasser</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Genetic and Laboratory Medicine, Laboratory Medicine Division, Geneva University, Geneva University Hospital and Swiss Centre of Applied Human Toxicology</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Simpson, Richard J" sort="Simpson, Richard J" uniqKey="Simpson R" first="Richard J." last="Simpson">Richard J. Simpson</name>
<affiliation><inist:fA14 i1="03"><s1>Ludwig Institute for Cancer Research Inc, Royal Melbourne Hospital</s1>
<s2>Parkville</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Proteomics : (Weinheim. Print)</title>
<title level="j" type="abbreviated">Proteomics : (Weinh., Print)</title>
<idno type="ISSN">1615-9853</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Proteomics : (Weinheim. Print)</title>
<title level="j" type="abbreviated">Proteomics : (Weinh., Print)</title>
<idno type="ISSN">1615-9853</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibody</term>
<term>Gene</term>
<term>Human</term>
<term>Protein</term>
<term>Proteome</term>
<term>Proteomics</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Homme</term>
<term>Gène</term>
<term>Protéome</term>
<term>Protéomique</term>
<term>Anticorps</term>
<term>Protéine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">With the recent developments in proteomic technologies, a complete human proteome project (HPP) appears feasible for the first time. However, there is still debate as to how it should be designed and what it should encompass. In "proteomics speak", the debate revolves around the central question as to whether a gene-centric or a protein-centric proteomics approach is the most appropriate way forward. In this paper, we try to shed light on what these definitions mean, how large-scale proteomics such as a HPP can insert into the larger omics chorus, and what we can reasonably expect from a HPP in the way it has been proposed so far.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1615-9853</s0>
</fA01>
<fA03 i2="1"><s0>Proteomics : (Weinh., Print)</s0>
</fA03>
<fA05><s2>10</s2>
</fA05>
<fA06><s2>17</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Is a gene-centric human proteome project the best way for proteomics to serve biology?</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>RABILLOUD (Thierry)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>HOCHSTRASSER (Denis)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SIMPSON (Richard J.)</s1>
</fA11>
<fA14 i1="01"><s1>Biochemistry and Biophysics of Integrated Systems, UMR CNRS-CEA-UJF 5092, CEA Grenoble, iRTSV/BSBBSI</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Genetic and Laboratory Medicine, Laboratory Medicine Division, Geneva University, Geneva University Hospital and Swiss Centre of Applied Human Toxicology</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Ludwig Institute for Cancer Research Inc, Royal Melbourne Hospital</s1>
<s2>Parkville</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>3067-3072</s1>
</fA20>
<fA21><s1>2010</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>27206</s2>
<s5>354000194246300010</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>50 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>10-0431596</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Proteomics : (Weinheim. Print)</s0>
</fA64>
<fA66 i1="01"><s0>DEU</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>With the recent developments in proteomic technologies, a complete human proteome project (HPP) appears feasible for the first time. However, there is still debate as to how it should be designed and what it should encompass. In "proteomics speak", the debate revolves around the central question as to whether a gene-centric or a protein-centric proteomics approach is the most appropriate way forward. In this paper, we try to shed light on what these definitions mean, how large-scale proteomics such as a HPP can insert into the larger omics chorus, and what we can reasonably expect from a HPP in the way it has been proposed so far.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A02D10</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Homme</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Human</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Gène</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Gene</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Gen</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Protéome</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Proteome</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Proteoma</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Protéomique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Proteomics</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Proteómica</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Anticorps</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Antibody</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Anticuerpo</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Protéine</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Protein</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Proteína</s0>
<s5>09</s5>
</fC03>
<fN21><s1>284</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 10-0431596 INIST</NO>
<ET>Is a gene-centric human proteome project the best way for proteomics to serve biology?</ET>
<AU>RABILLOUD (Thierry); HOCHSTRASSER (Denis); SIMPSON (Richard J.)</AU>
<AF>Biochemistry and Biophysics of Integrated Systems, UMR CNRS-CEA-UJF 5092, CEA Grenoble, iRTSV/BSBBSI/Grenoble/France (1 aut.); Department of Genetic and Laboratory Medicine, Laboratory Medicine Division, Geneva University, Geneva University Hospital and Swiss Centre of Applied Human Toxicology/Geneva/Suisse (2 aut.); Ludwig Institute for Cancer Research Inc, Royal Melbourne Hospital/Parkville/Australie (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Proteomics : (Weinheim. Print); ISSN 1615-9853; Allemagne; Da. 2010; Vol. 10; No. 17; Pp. 3067-3072; Bibl. 50 ref.</SO>
<LA>Anglais</LA>
<EA>With the recent developments in proteomic technologies, a complete human proteome project (HPP) appears feasible for the first time. However, there is still debate as to how it should be designed and what it should encompass. In "proteomics speak", the debate revolves around the central question as to whether a gene-centric or a protein-centric proteomics approach is the most appropriate way forward. In this paper, we try to shed light on what these definitions mean, how large-scale proteomics such as a HPP can insert into the larger omics chorus, and what we can reasonably expect from a HPP in the way it has been proposed so far.</EA>
<CC>002A02D10</CC>
<FD>Homme; Gène; Protéome; Protéomique; Anticorps; Protéine</FD>
<ED>Human; Gene; Proteome; Proteomics; Antibody; Protein</ED>
<SD>Hombre; Gen; Proteoma; Proteómica; Anticuerpo; Proteína</SD>
<LO>INIST-27206.354000194246300010</LO>
<ID>10-0431596</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002383 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002383 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:10-0431596 |texte= Is a gene-centric human proteome project the best way for proteomics to serve biology? }}
This area was generated with Dilib version V0.6.33. |